- Home
- FBIO vs ATRA Comparison
FBIO vs ATRA Comparison
Compare FBIO & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- ATRA
- Stock Information
- Founded
- FBIO 2006
- ATRA 2012
- Country
- FBIO United States
- ATRA United States
- Employees
- FBIO N/A
- ATRA N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FBIO Health Care
- ATRA Health Care
- Exchange
- FBIO Nasdaq
- ATRA Nasdaq
- Market Cap
- FBIO 48.2M
- ATRA 43.4M
- IPO Year
- FBIO N/A
- ATRA 2014
- Fundamental
- Price
- FBIO $1.80
- ATRA $9.27
- Analyst Decision
- FBIO Strong Buy
- ATRA Hold
- Analyst Count
- FBIO 4
- ATRA 6
- Target Price
- FBIO $16.33
- ATRA $24.88
- AVG Volume (30 Days)
- FBIO 661.5K
- ATRA 90.7K
- Earning Date
- FBIO 11-12-2024
- ATRA 10-30-2024
- Dividend Yield
- FBIO N/A
- ATRA N/A
- EPS Growth
- FBIO N/A
- ATRA N/A
- EPS
- FBIO N/A
- ATRA N/A
- Revenue
- FBIO $82,624,000.00
- ATRA $62,387,000.00
- Revenue This Year
- FBIO N/A
- ATRA $1,190.80
- Revenue Next Year
- FBIO $81.63
- ATRA N/A
- P/E Ratio
- FBIO N/A
- ATRA N/A
- Revenue Growth
- FBIO 31.68
- ATRA 809.03
- 52 Week Low
- FBIO $1.24
- ATRA $4.98
- 52 Week High
- FBIO $4.43
- ATRA $39.50
- Technical
- Relative Strength Index (RSI)
- FBIO 61.24
- ATRA 63.04
- Support Level
- FBIO $1.50
- ATRA $7.55
- Resistance Level
- FBIO $1.65
- ATRA $10.05
- Average True Range (ATR)
- FBIO 0.09
- ATRA 0.51
- MACD
- FBIO 0.05
- ATRA 0.21
- Stochastic Oscillator
- FBIO 91.49
- ATRA 72.63
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).